Sandbox/001: Difference between revisions
Gerald Chi (talk | contribs) m (→Management) |
Gerald Chi (talk | contribs) m (→Classification) |
||
(7 intermediate revisions by the same user not shown) | |||
Line 25: | Line 25: | ||
| align="center" style="background:#A5B2D6; width: 55px;"|'''CVP''' | | align="center" style="background:#A5B2D6; width: 55px;"|'''CVP''' | ||
| align="center" style="background:#A5B2D6; width: 55px;"|'''SVO2''' | | align="center" style="background:#A5B2D6; width: 55px;"|'''SVO2''' | ||
| align="center" style="background:#A5B2D6; width: 55px;"|'''Feature''' | |||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC; width: 80px;" align=center rowspan=3 |'''Cardiogenic'''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC; width: 200px;" |'''[[Ventricular septal defect|Acute Ventricular Septal Defect]]'''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑|| style="font-size: 90%; padding: 0 5px; background:#DCDCDC;" align=center |↑↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC; width: 80px;" align=center rowspan=3 |'''Cardiogenic'''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC; width: 200px;" |'''[[Ventricular septal defect|Acute Ventricular Septal Defect]]'''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑|| style="font-size: 90%; padding: 0 5px; background:#DCDCDC;" align=center |↑↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑ || style="font-size: 90%; padding: 0 5px; background: #DCDCDC; width: 200px;" rowspan=3 | ↑ JVP, hepatojugular reflux, S3, S4, murmurs | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" |'''[[Mitral regurgitation|Acute Mitral Regurgitation]]'''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" |'''[[Mitral regurgitation|Acute Mitral Regurgitation]]'''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ | ||
Line 40: | Line 41: | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" |'''[[Anaphylactic shock|Anaphylactic Shock]]'''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ — ↓↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" |'''[[Anaphylactic shock|Anaphylactic Shock]]'''|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑↑|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ — ↓↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓|| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑ | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" rowspan=1 align=center |'''Hypovolemic'''|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" |'''[[Volume depletion|Volume Depletion]]'''|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓↓||style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓↓|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓↓|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓ | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" rowspan=1 align=center |'''Hypovolemic'''|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" |'''[[Volume depletion|Volume Depletion]]'''|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓↓||style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓↓|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓↓|| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓|| ↓ JVP | ||
|- | |- | ||
|} | |} | ||
Line 68: | Line 69: | ||
{{Family tree|border=2|boxstyle=background: WhiteSmoke;| | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}} | {{Family tree|border=2|boxstyle=background: WhiteSmoke;| | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}} | ||
{{Family tree|border=2|boxstyle=background: WhiteSmoke;| | | | | | | | | | | | | C01 | | | | | | | | | | | | | |C01= | {{Family tree|border=2|boxstyle=background: WhiteSmoke;| | | | | | | | | | | | | C01 | | | | | | | | | | | | | |C01= | ||
<div style="text-align: left; height: | <div style="text-align: left; height: 520px; width: 200px; padding: 5px;"> | ||
'''Resuscitation''' <BR> | '''Resuscitation''' <BR> | ||
---- | ---- | ||
❑ 0.5—1 L every 10—15 minutes<sup>†</sup> <BR> | ❑ 0.5—1 L every 10—15 minutes<sup>†</sup> <BR> | ||
❑ ± Morphine 2—4 mg boluses <BR> | |||
❑ Ventilatory support <BR> | |||
'''Labs & Imaging''' <BR> | |||
---- | |||
❑ CBC/DC/SMA-7/PT/PTT <BR> | |||
❑ Arterial blood gas <BR> | |||
❑ Lactate <BR> | |||
❑ ECG <BR> | |||
❑ CXR <BR> | |||
❑ Echocardiography <BR> | |||
❑ CXR <BR> | |||
❑ Central venous catheter <BR> | |||
❑ Pulmonary artery catheter <BR> | |||
'''Immediate Goals''' <BR> | '''Immediate Goals''' <BR> | ||
---- | ---- | ||
Line 88: | Line 102: | ||
{{Family tree|border=2|boxstyle=background: WhiteSmoke;| | | | | | | | | | | | | D01 | | | | | | | | | | | | | |D01= | {{Family tree|border=2|boxstyle=background: WhiteSmoke;| | | | | | | | | | | | | D01 | | | | | | | | | | | | | |D01= | ||
<div style="text-align: left; height: 130px; width: 200px;"> | <div style="text-align: left; height: 130px; width: 200px;"> | ||
</div>}} | </div>}} | ||
{{Family tree/end}} | {{Family tree/end}} |
Latest revision as of 16:27, 5 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Circulatory shock
Definition
Shock is the clinical expression of circulatory failure that results in inadequate cellular oxygen utilization.[1]
Causes
Shock is a life-threatening condition and must be treated as such irrespective of the causes.
Classification
Type of Shock | CO | SVR | PCWP | CVP | SVO2 | Feature | |
Cardiogenic | Acute Ventricular Septal Defect | ↓↓ | ↑ | N — ↑ | ↑↑ | ↑ — ↑↑ | ↑ JVP, hepatojugular reflux, S3, S4, murmurs |
Acute Mitral Regurgitation | ↓↓ | ↑ | ↑↑ | ↑ — ↑↑ | ↓ | ||
Myocardial Infarction | ↓↓ | ↑ | ↑↑ | ↑↑ | ↓ | ||
Obstructive | Pulmonary Embolism | ↓↓ | ↑ | N — ↓ | ↑↑ | ↓ | |
Cardiac Tamponade | ↓ — ↓↓ | ↑ | ↑↑ | ↑↑ | ↓ | ||
Distributive | Septic Shock | N — ↑↑ | ↓ — ↓↓ | N — ↓ | N — ↓ | ↑ — ↑↑ | |
Anaphylactic Shock | N — ↑↑ | ↓ — ↓↓ | N — ↓ | N — ↓ | ↑ — ↑↑ | ||
Hypovolemic | Volume Depletion | ↓↓ | ↑ | ↓↓ | ↓↓ | ↓ | ↓ JVP |
Management
Symptoms & Signs ❑ Altered mental status | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shock | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Resuscitation ❑ 0.5—1 L every 10—15 minutes† ❑ CBC/DC/SMA-7/PT/PTT ❑ MAP >60—65 mmHg | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
† 100—200 mL boluses for cardiogenic shock
References
- ↑ Vincent, JL.; De Backer, D. (2013). "Circulatory shock". N Engl J Med. 369 (18): 1726–34. doi:10.1056/NEJMra1208943. PMID 24171518. Unknown parameter
|month=
ignored (help) - ↑ Parrillo, Joseph E.; Ayres, Stephen M. (1984). Major issues in critical care medicin. Baltimore: William Wilkins. ISBN 0-683-06754-0.
- ↑ Weil, Max Harry; Shubin, Herbert (1967). Diagnosis and Treatment of Shock. Williams & Wilkins. ISBN 1125885874.